Dunn Jessilyn, Simmons Rachel, Thabet Salim, Jo Hanjoong
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, USA.
Division of Cardiology, Georgia Institute of Technology and Emory University, USA.
Int J Biochem Cell Biol. 2015 Oct;67:167-76. doi: 10.1016/j.biocel.2015.05.001. Epub 2015 May 13.
Currently in the field of vascular biology, the role of epigenetics in endothelial cell biology and vascular disease has attracted more in-depth study. Using both in vitro and in vivo models of blood flow, investigators have recently begun to reveal the underlying epigenetic regulation of endothelial gene expression. Recently, our group, along with two other independent groups, have demonstrated that blood flow controls endothelial gene expression by DNA methyltransferases (DNMT1 and 3A). Disturbed flow (d-flow), characterized by low and oscillating shear stress (OS), is pro-atherogenic and induces expression of DNMT1 both in vivo and in vitro. D-flow regulates genome-wide DNA methylation patterns in a DNMT-dependent manner. The DNMT inhibitor 5-Aza-2'deoxycytidine (5Aza) or DNMT1 siRNA reduces OS-induced endothelial inflammation. Moreover, 5Aza inhibits the development of atherosclerosis in ApoE(-/-) mice. Through a systems biological analysis of genome-wide DNA methylation patterns and gene expression data, we found 11 mechanosensitive genes which were suppressed by d-flow in vivo, experienced hypermethylation in their promoter region in response to d-flow, and were rescued by 5Aza treatment. Interestingly, among these mechanosensitive genes, the two transcription factors HoxA5 and Klf3 contain cAMP-response-elements (CRE), which may indicate that methylation of CRE sites could serve as a mechanosensitive master switch in gene expression. These findings provide new insight into the mechanism by which flow controls epigenetic DNA methylation patterns, which in turn alters endothelial gene expression, regulates vascular biology, and induces atherosclerosis. These novel findings have broad implications for understanding the biochemical mechanisms of atherogenesis and provide a basis for identifying potential therapeutic targets for atherosclerosis. This article is part of a Directed Issue entitled: Epigenetics dynamics in development and disease.
目前在血管生物学领域,表观遗传学在内皮细胞生物学和血管疾病中的作用已吸引了更深入的研究。利用体外和体内血流模型,研究人员最近开始揭示内皮基因表达潜在的表观遗传调控机制。最近,我们团队与另外两个独立团队证明,血流通过DNA甲基转移酶(DNMT1和3A)控制内皮基因表达。紊乱血流(d-flow)的特征是低且振荡的剪切应力(OS),具有促动脉粥样硬化作用,并在体内和体外诱导DNMT1的表达。d-flow以DNMT依赖的方式调节全基因组DNA甲基化模式。DNMT抑制剂5-氮杂-2'-脱氧胞苷(5Aza)或DNMT1 siRNA可减轻OS诱导的内皮炎症。此外,5Aza可抑制ApoE(-/-)小鼠动脉粥样硬化的发展。通过对全基因组DNA甲基化模式和基因表达数据进行系统生物学分析,我们发现11个机械敏感基因在体内被d-flow抑制,其启动子区域在d-flow作用下发生高甲基化,并通过5Aza处理得以恢复。有趣的是,在这些机械敏感基因中,两个转录因子HoxA5和Klf3含有cAMP反应元件(CRE),这可能表明CRE位点的甲基化可作为基因表达中的机械敏感主开关调控机制。这些发现为血流控制表观遗传DNA甲基化模式进而改变内皮基因表达、调节血管生物学并诱导动脉粥样硬化的机制提供了新见解。这些新发现对理解动脉粥样硬化的生化机制具有广泛意义,并为确定动脉粥样硬化的潜在治疗靶点提供了依据。本文是名为《发育与疾病中的表观遗传学动态》的特刊文章的一部分。